Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC

Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC

Non-small cell lung cancer (NSCLC) constitutes the majority of the lung cancer population and the prognosis is poor. In recent years, immunotherapy has become the standard of care for advanced NSCLC patients as numerous trials demonstrated that immune checkpoint inhibitors (ICI) are more efficacious...

Full description

Bibliographic Details
Main Authors: Kah Yee Goh, Terence You De Cheng, Su Chin Tham, Darren Wan-Teck Lim
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Biomedicines
Subjects:
liquid biopsy
biomarkers
immunotherapy
checkpoint inhibition
lung cancer
Online Access:https://www.mdpi.com/2227-9059/11/2/508

Similar Items

Similar Items